BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29632073)

  • 21. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
    Song G; Zhang Z; Wen L; Chen C; Shi Q; Zhang Y; Ni J; Liu Q
    J Alzheimers Dis; 2014; 41(1):85-99. PubMed ID: 24577479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
    Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease.
    Goutagny R; Gu N; Cavanagh C; Jackson J; Chabot JG; Quirion R; Krantic S; Williams S
    Eur J Neurosci; 2013 Jun; 37(12):1896-902. PubMed ID: 23773058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairments in spatial representations and rhythmic coordination of place cells in the 3xTg mouse model of Alzheimer's disease.
    Mably AJ; Gereke BJ; Jones DT; Colgin LL
    Hippocampus; 2017 Apr; 27(4):378-392. PubMed ID: 28032686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.
    Arner A; Rockenstein E; Mante M; Florio J; Masliah D; Salehi B; Adame A; Overk C; Masliah E; Rissman RA
    J Alzheimers Dis; 2018; 61(3):1201-1219. PubMed ID: 29332037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.
    Laurent C; Eddarkaoui S; Derisbourg M; Leboucher A; Demeyer D; Carrier S; Schneider M; Hamdane M; Müller CE; Buée L; Blum D
    Neurobiol Aging; 2014 Sep; 35(9):2079-90. PubMed ID: 24780254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disrupted hippocampal sharp-wave ripple-associated spike dynamics in a transgenic mouse model of dementia.
    Witton J; Staniaszek LE; Bartsch U; Randall AD; Jones MW; Brown JT
    J Physiol; 2016 Aug; 594(16):4615-30. PubMed ID: 25480798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer's disease mice.
    Qiu L; Ng G; Tan EK; Liao P; Kandiah N; Zeng L
    Sci Rep; 2016 Apr; 6():23964. PubMed ID: 27050297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice.
    Dai CL; Hu W; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2018 Jan; 10(1):13. PubMed ID: 29386065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease.
    Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG
    J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau-dependent Kv4.2 depletion and dendritic hyperexcitability in a mouse model of Alzheimer's disease.
    Hall AM; Throesch BT; Buckingham SC; Markwardt SJ; Peng Y; Wang Q; Hoffman DA; Roberson ED
    J Neurosci; 2015 Apr; 35(15):6221-30. PubMed ID: 25878292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX; Zhao RP; Wang DS; Wang AN
    Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy.
    Loreth D; Ozmen L; Revel FG; Knoflach F; Wetzel P; Frotscher M; Metzger F; Kretz O
    Neurobiol Dis; 2012 Jul; 47(1):1-12. PubMed ID: 22426397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.
    Ando K; Maruko-Otake A; Ohtake Y; Hayashishita M; Sekiya M; Iijima KM
    PLoS Genet; 2016 Mar; 12(3):e1005917. PubMed ID: 27023670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.